pf-04958242
Showing 1 - 11 of 11
Schizophrenia Trial in Long Beach (PF-04958242, Placebo)
Completed
- Schizophrenia
- PF-04958242
- Placebo
-
Long Beach, CaliforniaCollaborative Neuroscience Network, LLC.
Oct 4, 2021
Healthy Volunteer Trial in Singapore (PF-04958242, Placebo)
Completed
- Healthy Volunteer
- PF-04958242
- Placebo
-
Singapore, SingaporeResearch Site
Dec 20, 2019
Schizophrenia Trial in New Haven (PF-04958242, Placebo)
Completed
- Schizophrenia
- PF-04958242
- Placebo
-
New Haven, ConnecticutPfizer Investigational Site
Nov 19, 2019
Healthy Trial in New Haven (PF-04958242, Itraconazole)
Completed
- Healthy
- PF-04958242
- Itraconazole
-
New Haven, ConnecticutPfizer New Haven Clinical Research Unit
Dec 20, 2019
Healthy Volunteers Trial in Singapore (PF-04958242, Placebo)
Terminated
- Healthy Volunteers
- PF-04958242
- Placebo
-
Singapore, SingaporeResearch Site
Dec 20, 2019
Schizophrenia Trial in Long Beach (PF-04958242, Placebo)
Completed
- Schizophrenia
- PF-04958242
- Placebo
-
Long Beach, CaliforniaPfizer Investigational Site
Nov 19, 2019
Healthy Trial in New Haven (PF-04958242, Placebo)
Completed
- Healthy
- PF-04958242
- Placebo
-
New Haven, ConnecticutNew Haven Clinical Research Unit
Dec 23, 2019
Healthy Volunteer Trial in New Haven (Placebo, PF-04958242)
Completed
- Healthy Volunteer
- Placebo
- PF-04958242
-
New Haven, Connecticut
- +1 more
Dec 20, 2019
Schizophrenia Trial in New Haven, West Haven (PF-04958242, Ketamine, Placebo)
Completed
- Schizophrenia
- PF-04958242
- +2 more
-
New Haven, Connecticut
- +1 more
Nov 19, 2019
Hearing Loss, Sensorineural Trial in United States (PF-04958242, Placebo)
Completed
- Hearing Loss, Sensorineural
- PF-04958242
- Placebo
-
Anaheim, California
- +10 more
Nov 19, 2019
Cognitive Impairment Associated With Schizophrenia (CIAS) Trial in United States (PF-04958242, )
Terminated
- Cognitive Impairment Associated With Schizophrenia (CIAS)
- PF-04958242
- placebo
-
Garden Grove, California
- +15 more
Dec 20, 2019